By Yasser Mushtaq, Senior Analyst, GBI Research | March 27, 2017Global Respiratory Complications Market to Exceed $30B by 2022
By Yasser Mushtaq, Senior Analyst, GBI Research | August 22, 2016CF Therapies Will Push Vertex Ahead of GSK in $46.6B Respiratory Market by 2022